NCT05318456 - The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

January 19, 2023

Study Completion Date

March 20, 2023

Conditions

Mood

Interventions

DIETARY_SUPPLEMENT

MoodElite T-4003-1

Participants will be instructed to take two capsules of MoodElite T-4003-1 once daily with water, after dinner without food for 42 days.

DIETARY_SUPPLEMENT

Comparator

Participants will be instructed to take two capsules of comparator once daily with water, after dinner without food for 42 days.

OTHER

Placebo

Participants will be instructed to take two capsules of placebo once daily with water, after dinner without food for 42 days.

Trial Locations (1)

KGK Science Inc., London